Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalo Therapeutics (AVTX) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Avalo Therapeutics (AVTX) over the last 12 years, with Q3 2025 value amounting to $2.1 million.

  • Avalo Therapeutics' Prepaid Assets rose 13766.67% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 13766.67%. This contributed to the annual value of $4.3 million for FY2024, which is 41304.86% up from last year.
  • Per Avalo Therapeutics' latest filing, its Prepaid Assets stood at $2.1 million for Q3 2025, which was up 13766.67% from $1.9 million recorded in Q2 2025.
  • In the past 5 years, Avalo Therapeutics' Prepaid Assets registered a high of $4.3 million during Q4 2024, and its lowest value of $100000.0 during Q1 2024.
  • In the last 5 years, Avalo Therapeutics' Prepaid Assets had a median value of $1.6 million in 2023 and averaged $1.6 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first tumbled by 9385.37% in 2024, then surged by 180300.0% in 2025.
  • Avalo Therapeutics' Prepaid Assets (Quarter) stood at $2.4 million in 2021, then plummeted by 45.62% to $1.3 million in 2022, then crashed by 34.65% to $843000.0 in 2023, then soared by 413.05% to $4.3 million in 2024, then crashed by 50.54% to $2.1 million in 2025.
  • Its Prepaid Assets was $2.1 million in Q3 2025, compared to $1.9 million in Q2 2025 and $1.8 million in Q1 2025.